The Briefing

Continuous newsroom coverage of clinically relevant evidence — newest first.

Earlier

24 stories
  1. Plasma GFAP and NfL Predict Long-Term Mortality in Older Adults
    Neurology ·Cohort Study · March 17, 2026

    Plasma GFAP and NfL Predict Long-Term Mortality in Older Adults

    Elevated baseline levels of GFAP and NfL strongly correlate with future risk of all-cause, dementia, and cardiovascular death.

  2. Adhesions Drive Most Small Bowel Obstructions in the Virgin Abdomen
    World Journal of Emergency Surgery ·Cohort Study · March 17, 2026

    Adhesions Drive Most Small Bowel Obstructions in the Virgin Abdomen

    A retrospective study of 312 patients shows conservative management is feasible, with a 4.9% mortality rate in non-operative cases.

  3. Algorithm Predicts Parkinsonism Pathology From Clinical Symptoms
    Annals of Neurology ·Diagnostic Accuracy Study · March 17, 2026

    Algorithm Predicts Parkinsonism Pathology From Clinical Symptoms

    A machine learning tool trained on brain bank data uses 23 clinical parameters to accurately predict post-mortem pathology in parkinsonism.

  4. Inhibiting USP22 Halts Periodontitis-Linked Brain Inflammation in Mice
    Frontiers in Neuroscience ·In Vitro Study · March 17, 2026

    Inhibiting USP22 Halts Periodontitis-Linked Brain Inflammation in Mice

    Knocking down the enzyme USP22 in mice prevents the periodontal pathogen P. gingivalis from degrading blood-brain barrier tight junctions.

  5. Women Face Worse Functional Recovery After Intensive Care EEG
    Critical Care Medicine ·Randomized Controlled Trial · March 17, 2026

    Women Face Worse Functional Recovery After Intensive Care EEG

    Despite similar acute management and mortality, critically ill women are half as likely as men to achieve favorable long-term recovery.

  6. Baseline Breathing Patterns Predict Post-Seizure Hypoxemia Severity
    Neurology ·Cohort Study · March 17, 2026

    Baseline Breathing Patterns Predict Post-Seizure Hypoxemia Severity

    Measuring respiratory variability between seizures may help identify epilepsy patients at highest risk for severe oxygen desaturation.

  7. Brain Imaging Maps How Deep Brain Stimulation Alters Parkinson's Circuits
    Nature Neuroscience ·Case Series · March 17, 2026

    Brain Imaging Maps How Deep Brain Stimulation Alters Parkinson's Circuits

    Extensive functional MRI data from 14 patients reveals that cortical connectivity patterns can predict clinical outcomes of stimulation.

  8. Structured Diagnostic Approach Guides Management of Chronic Diarrhea
    JAMA ·Narrative Review · March 16, 2026

    Structured Diagnostic Approach Guides Management of Chronic Diarrhea

    A comprehensive clinical review details specific red flags for endoscopic evaluation and outlines empiric therapies that improve symptoms.

  9. Social Isolation Linked to Mood Episodes in Youth Bipolar Disorder
    Frontiers in Psychiatry ·Systematic Review · March 16, 2026

    Social Isolation Linked to Mood Episodes in Youth Bipolar Disorder

    A scoping review of 522 patients identifies loneliness as a marker of poor psychosocial function and altered neural social processing.

  10. Decision Tool Reduces Antidepressant Discontinuation in Depression
    JAMA ·Randomized Controlled Trial · March 16, 2026

    Decision Tool Reduces Antidepressant Discontinuation in Depression

    A web-based system personalizing antidepressant selection kept more patients on therapy at 8 weeks and improved symptoms at 24 weeks.

  11. Glutamate Levels Link to EEG Hyperexcitability in Borderline Personality Disorder
    Frontiers in Psychiatry ·Cross-Sectional Study · March 16, 2026

    Glutamate Levels Link to EEG Hyperexcitability in Borderline Personality Disorder

    Metabolic imaging reveals that glutamate ratios in the nucleus accumbens and cingulate cortex correlate with neural instability markers.

  12. Obinutuzumab Shows High Efficacy in Active Systemic Lupus Erythematosus
    New England Journal of Medicine ·Randomized Controlled Trial · March 16, 2026

    Obinutuzumab Shows High Efficacy in Active Systemic Lupus Erythematosus

    A phase 3 trial shows the anti-CD20 antibody obinutuzumab significantly improves clinical responses and reduces flares in active lupus.

  13. Pimicotinib Yields 54% Response in Tenosynovial Giant Cell Tumors
    The Lancet ·Randomized Controlled Trial · March 15, 2026

    Pimicotinib Yields 54% Response in Tenosynovial Giant Cell Tumors

    The selective inhibitor pimicotinib demonstrates high efficacy for unresectable joint tumors while avoiding severe hepatotoxicity.

  14. Zorevunersen Cuts Convulsive Seizures in Children With Dravet Syndrome
    New England Journal of Medicine ·Randomized Controlled Trial · March 15, 2026

    Zorevunersen Cuts Convulsive Seizures in Children With Dravet Syndrome

    The investigational antisense therapy reduced convulsive-seizure frequency by up to 90.91% and improved adaptive behavior over 36 months.

  15. Seven Hours of Sleep Maximizes Depression Risk Reduction in Older Adults
    Frontiers in Psychiatry ·Cross-Sectional Study · March 15, 2026

    Seven Hours of Sleep Maximizes Depression Risk Reduction in Older Adults

    A national cross-sectional study reveals a non-linear relationship where the mental health benefits of sleep attenuate after seven hours.

  16. ADHD Linked to Attenuated Rightward Structural Asymmetry in Children
    Frontiers in Neuroscience ·Cross-Sectional Study · March 15, 2026

    ADHD Linked to Attenuated Rightward Structural Asymmetry in Children

    MRI data reveal that reduced right-hemisphere dominance in frontal and striatal regions correlates with impaired attention and timing.

  17. Finerenone Reduces Albuminuria in Type 1 Diabetes and CKD
    New England Journal of Medicine ·Randomized Controlled Trial · March 15, 2026

    Finerenone Reduces Albuminuria in Type 1 Diabetes and CKD

    A phase 3 trial shows the mineralocorticoid receptor antagonist finerenone safely lowers albuminuria in adults with type 1 diabetes.

  18. Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension
    The Lancet ·Randomized Controlled Trial · March 15, 2026

    Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension

    A phase 3 trial shows the selective aldosterone synthase inhibitor baxdrostat reduces systolic blood pressure by 14 mm Hg versus placebo.

  19. Neoadjuvant GOLP Doubles Event-Free Survival in Cholangiocarcinoma
    New England Journal of Medicine ·Randomized Controlled Trial · March 15, 2026

    Neoadjuvant GOLP Doubles Event-Free Survival in Cholangiocarcinoma

    Administering the GOLP regimen before surgery extends median event-free survival to 18 months in high-risk intrahepatic cholangiocarcinoma.

  20. LGBTQ+ EMS Clinicians Balance Professional Identity and Disclosure
    Prehospital Emergency Care ·Qualitative Study · March 15, 2026

    LGBTQ+ EMS Clinicians Balance Professional Identity and Disclosure

    A qualitative analysis reveals how LGBTQ+ prehospital clinicians navigate workplace disclosure while prioritizing their clinical skills.

  21. Sleep Under 6.7 Hours Linked to Depression in Opioid Users
    Frontiers in Psychiatry ·Cohort Study · March 15, 2026

    Sleep Under 6.7 Hours Linked to Depression in Opioid Users

    A U-shaped dose-response curve reveals that insufficient sleep increases depression risk by 60% among adults taking prescription opioids.

  22. Lab and Point-of-Care Electrolyte Tests Diverge in 10% of ICU Cases
    Critical Care Medicine ·Cross-Sectional Study · March 15, 2026

    Lab and Point-of-Care Electrolyte Tests Diverge in 10% of ICU Cases

    A prospective study reveals that central lab and point-of-care sodium and potassium measurements are not interchangeable in critical care.

  23. Digital Dyadic Interventions Improve Cognition and Reduce Caregiver Burden
    Frontiers in Psychiatry ·Systematic Review · March 15, 2026

    Digital Dyadic Interventions Improve Cognition and Reduce Caregiver Burden

    A review of 38 studies finds digital tools like mobile apps and remote platforms enhance patient cognition and ease caregiver burden.

  24. Real-World CBT Improves Distress but Not Pain in Functional Neurological Disorder
    Frontiers in Psychiatry ·Cohort Study · March 15, 2026

    Real-World CBT Improves Distress but Not Pain in Functional Neurological Disorder

    Routine clinical data from 234 adults shows cognitive behavioral therapy significantly reduces psychological distress but not physical pain.